• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Biogen Inc. (BIIB)

    -NasdaqGS
    404.28 Down 1.13(0.28%) Jul 2, 4:00PM EDT
    |After Hours : 403.25 Down 1.03 (0.25%) Jul 2, 5:52PM EDT
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2014Dec 31, 2013Dec 31, 2012
    Total Revenue 9,703,324   6,932,199   5,516,461  
    Cost of Revenue1,171,036  857,726  545,494  
    Gross Profit 8,532,288   6,074,473   4,970,967  
    Operating Expenses
    Research Development1,893,422  1,444,053  1,334,919  
    Selling General and Administrative2,193,449  1,796,861  1,622,562  
    Non Recurring -   -  2,225  
    Others489,761  342,948  202,204  
    Total Operating Expenses -   -  3,161,910  
    Operating Income or Loss 3,972,414   2,515,509   1,855,849  
    Income from Continuing Operations
    Total Other Income/Expenses Net(9,023)(10,032)46,048  
    Earnings Before Interest And Taxes3,963,391  2,505,477  1,901,897  
    Interest Expense -   -   -  
    Income Before Tax3,963,391  2,505,477  1,901,897  
    Income Tax Expense989,942  601,014  470,554  
    Minority Interest(6,781) -   -  
    Net Income From Continuing Ops2,951,542  1,887,239  1,426,825  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 2,934,784   1,862,341   1,380,033  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 2,934,784   1,862,341   1,380,033  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.